UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (Date of Earliest Event Reported): May 27, 2004

                               CINEMARK USA, INC.
               (Exact name of registrant as specified in charter)


             TEXAS                     33-47040                   75-2206284
 (State or Other Jurisdiction         (Commission               (IRS Employer
       of Incorporation)              File Number)           Identification No.)


                         3900 DALLAS PARKWAY, SUITE 500
                               PLANO, TEXAS 75093
              (Address and Zip Code of Principal Executive Offices)

                                  972-665-1000
              (Registrant's telephone number, including area code)


Item 9. Regulation FD Disclosure

On May 27, 2004,  Cinemark USA, Inc. announced that it has accepted for purchase
and  payment,  pursuant to a change of control  offer to  purchase,  any and all
outstanding 9% Senior Subordinated Notes due 2013 that were validly tendered and
not  withdrawn  prior to 5:00  p.m.,  New York City time,  on May 26,  2004 (the
"Expiration  Date").  A copy of the press  release  is  furnished  to the United
States Securities and Exchange  Commission (the  "Commission") with this current
report on Form 8-K as an exhibit.



                                    SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                         CINEMARK USA, INC.


Date: May 27, 2004                       By:    /s/ Michael D. Cavalier
                                         Name:  Michael D. Cavalier
                                         Title: Vice President - General Counsel



                                  EXHIBIT INDEX

        The exhibits below are numbered in accordance  with the Exhibit Table of
Item 601 of Regulation 8-K.

Exhibit No.            Description of Exhibit

99.1                   Press Release of Cinemark USA, Inc. dated May 27, 2004.



                                                                    EXHIBIT 99.1

Cinemark  USA,  Inc.  Announces  Expiration of its Change of Control Debt Tender
Offer

PLANO,  Texas--May 27, 2004--Cinemark USA, Inc. (the "Company") announced  today
that it has accepted  for purchase and payment,  pursuant to a change of control
offer to purchase, any and all outstanding 9% Senior Subordinated Notes due 2013
(the "Notes") that were validly  tendered and not withdrawn  prior to 5:00 p.m.,
New York City time, on May 26, 2004 (the "Expiration Date"). The Expiration Date
marks the expiration of the change of control offer, which was launched on April
6, 2004.

Holders of Notes who  tendered  their Notes on or prior to the  Expiration  Date
will receive total consideration equal to 101% of the aggregate principal amount
of the Notes  validly  tendered  plus  accrued and unpaid  interest  to, but not
including,  the date of purchase ("Change of Control Offer Price").  The Company
will pay the Change of Control Offer Price on June 1, 2004.

An  aggregate  principal  amount of $17.75  million  of the Notes  were  validly
tendered and not  withdrawn as of 5:00 p.m.,  New York time,  on the  Expiration
Date. Upon purchase of the Notes tendered on June 1, 2004, approximately $342.25
million in aggregate principal amount of the Notes will remain outstanding.

This press release shall not  constitute an offer to purchase or a  solicitation
of acceptance of the tender offer,  which may be made only pursuant to the terms
of the offer to purchase and the related transmittal documents.

The Company  intends  that this press  release be governed by the "safe  harbor"
provision  of the Private  Securities  Litigation  Reform Act of 1995 (the "PSLR
Act")  with  respect  to  statements  that may be deemed  to be  forward-looking
statements under the PSLR Act. Such forward-looking  statements may include, but
are not limited to, the Company and any of its  subsidiaries'  long-term theatre
strategy.  Actual results could differ  materially  from those indicated by such
forward-looking statements due to a number of factors.